The average of price targets set by Wall Street analysts indicates a potential upside of 77.3% in Enovis (ENOV). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

The average of price targets set by Wall Street analysts indicates a potential upside of 45.6% in CorMedix (CRMD). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

TPG RE Finance Trust, Inc. (TRTX) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, TRTX's 50-day simple moving average crossed above its 200-day simple moving average, known as a "golden cross.

Dorman Products, Inc. (DORM) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, DORM's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross.

The average of price targets set by Wall Street analysts indicates a potential upside of 106.2% in XOMA Royalty (XOMA). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

The average of price targets set by Wall Street analysts indicates a potential upside of 149.7% in Mineralys Therapeutics, Inc. (MLYS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

The consensus price target hints at a 26.7% upside potential for Kiniksa Pharmaceuticals International, plc (KNSA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

The consensus price target hints at a 101% upside potential for Rapt Therapeutics (RAPT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Freightos Limited (NASDAQ:CRGO ) Q2 2025 Earnings Conference Call August 18, 2025 8:30 AM ET Company Participants Anat Earon-Heilborn - Corporate Participant Pablo Pinillos - Chief Financial Officer Udo Lange - Former President Zvi Schreiber - CEO & Director Conference Call Participants George Frederick Sutton - Craig-Hallum Capital Group LLC, Research Division Anat Earon-Heilborn Hello, and welcome to Freightos Q2 2025 Earnings Conference Call. A press release with detailed financial results was released earlier today and is available on the Investor Relations section of our website, freightos.com/investors.

TotalEnergies stands out with a diversified portfolio, strong LNG presence, and resilient financials, even amid lower oil prices. Ongoing growth is fueled by new upstream projects, expanding renewables, and strategic LNG deals, supporting future cash flow and production. Shareholder returns remain robust, with a 4%+ dividend yield and buybacks, underpinned by disciplined capex and manageable payout ratios.

I am upgrading Advanced Micro Devices, Inc. to hold with a $202/share target, reflecting strong Client & Gaming growth offsetting Data Center deceleration. AMD is gaining market share from Intel, with robust Ryzen and EPYC sales and expanding gaming partnerships with Microsoft and Sony driving future upside. Data Center growth faced some headwinds in Q2 '25 from export controls and inventory write-downs, but Chinese market sales could resume pending export license approvals.

ZIM faces Q2 earnings with higher EPS estimates but steep year-over-year declines, rising costs, and trade tensions clouding its outlook.

OUT shares jump 14.5% in three months as digital conversions, acquisitions and transit growth fuel momentum.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.